Fall 2026 Respiratory Virus Update: What the Latest CDC Data Says About COVID, Flu and RSV

• The CDC reported on October 16, 2026, that COVID-19 emergency-department visits were highest among children younger than 5, while COVID-19 hospitalizations remained highest among adults 65 and older.
• RSV emergency visits among children under 5 were still low but beginning to rise. National flu and RSV hospitalization rates also remained low in the CDC’s latest update.
• These figures are national surveillance signals, not a diagnosis or a forecast for every community. Families should watch symptoms, consider age-related risk, and seek prompt care for warning signs.

What the CDC’s October 2026 respiratory virus update shows

The CDC’s October 16, 2026 update does not point to one respiratory virus affecting everyone in the same way. Instead, the pattern changes substantially by age and by virus.

COVID-19 emergency-department visits were highest among children younger than 5, while COVID-19 hospitalizations remained highest among adults 65 and older. RSV emergency-department visits among children under 5 were low but beginning to increase. At the national level, hospitalization rates for COVID-19, flu and RSV remained low.

The CDC’s age-specific data were presented through September 26, 2026, so the update should be read as a recent surveillance snapshot rather than a prediction of what will happen throughout the fall and winter.

What is confirmed in the U.S. data

There are two important details behind those headlines. First, a higher percentage of emergency-department visits does not necessarily mean that a group has the highest hospitalization rate. Emergency visits measure demand for urgent care, while hospitalization data reflect more serious illness and the people most likely to need inpatient treatment.

Second, the CDC warns that some estimates are preliminary and may be revised as delayed reports are added. Temporary interruptions to data feeds can also affect current estimates. That matters when comparing one week with another.

What this means for families and older adults

For families with babies or young children, the early RSV increase is worth watching without treating it as proof that a severe RSV wave is underway. RSV commonly causes cold-like symptoms, but infants can develop breathing problems, poor feeding or dehydration. A child’s age, medical history and symptoms matter more than a national headline alone.

For adults 65 and older, the CDC’s hospitalization pattern is a reminder that COVID-19 can still lead to more serious illness in this age group even when national hospitalization levels are low. Older adults and people with certain medical conditions should have a plan for contacting a healthcare provider early if symptoms begin.

For healthy adults and school-age children, the current data do not suggest that every cough requires emergency care. They do suggest paying attention to local activity, staying home when sick, and avoiding close contact with people who are more likely to become seriously ill.

Questions worth asking a healthcare provider

• Does my age or medical history put me at higher risk from COVID-19, flu or RSV?
• If symptoms begin, should I call promptly about testing or prescription antiviral treatment?
• Are recommended vaccines or RSV prevention products appropriate for my household?
• Which symptoms should lead us to call the office, use urgent care or go directly to an emergency department?

Flu and COVID-19 antiviral medicines work best when started early and require a prescription in the United States. A clinician can explain whether treatment is appropriate and how quickly it should begin.

How to use national data without overreading it

National surveillance is useful for spotting broad patterns, but it cannot tell you exactly what is circulating in your neighborhood or whether a particular illness is COVID-19, flu, RSV or another virus. Local conditions can change at different speeds, especially during the start of respiratory virus season.

People in the United States can use the CDC’s Respiratory Illnesses Data Channel for current national and local indicators. Canadian readers should use Canada’s FluWatch+ dashboard instead, because the CDC data describe the United States and should not be treated as Canadian surveillance.

What Canadian readers should know

The CDC update is U.S.-specific, but Canada’s latest FluWatch+ snapshot, updated October 30, 2026 with data through October 24, shows a somewhat similar early-season picture: influenza activity was increasing but classified as low, COVID-19 activity remained low while test positivity was increasing, and RSV activity remained very low and stable at interseasonal levels.

Canada also reported that the 2026–2027 influenza season began in surveillance week 40, ending October 10, which was considered an early start. Respiratory hospitalization rates were increasing but remained low nationally, and pediatric respiratory hospitalizations were stable at low levels.

Those Canadian figures are not interchangeable with the CDC’s age-specific U.S. findings. Healthcare systems, testing practices, reporting networks and population patterns differ between the two countries.

When respiratory symptoms need urgent attention

Seek emergency medical care immediately for trouble breathing, bluish lips or face, chest pain, confusion, seizures or severe weakness. In children, additional warning signs include ribs pulling in with each breath, fast breathing, dehydration, unusual lack of alertness or a fever of 100.4°F (38°C) or higher in a baby younger than 12 weeks.

A fever or cough that improves and then returns or worsens is another reason to seek medical advice promptly. These warning signs apply regardless of whether the illness is confirmed as COVID-19, flu, RSV or another respiratory infection.

Practical status for fall 2026

The clearest takeaway is not that one virus has taken over. It is that COVID-19 is producing different age patterns, RSV is beginning to show more activity among young children, and flu is starting to increase while overall hospitalization levels remain low. Use the data to decide how closely to monitor symptoms and when to call a clinician—not to diagnose an individual illness from national statistics.

Helpful Links

• CDC People Most Impacted by Respiratory Viruses – Review the CDC’s age-specific emergency-department and hospitalization trends for COVID-19, flu and RSV.
• CDC Hospitalizations and Deaths – See national hospitalization levels and surveillance notes for the three major respiratory viruses.
• CDC About Respiratory Illnesses – Read CDC guidance on symptoms, treatment timing and emergency warning signs.
• Canadian Respiratory Virus Surveillance Report – Compare current Canadian trends for COVID-19, influenza and RSV through the FluWatch+ dashboard.
• Respiratory Illnesses Data Channel – Official page referenced in the article.
• Treatment of Respiratory Viruses – Official page referenced in the article.

Frequently Asked Questions

Q. Does the CDC update mean RSV is already causing a major wave in children?

A. No. The CDC said RSV emergency-department visits among children under 5 were low but beginning to rise. That is an early trend signal, not evidence that a major national wave is already underway.

Q. Why are COVID-19 emergency visits highest among young children but hospitalizations highest among older adults?

A. Emergency-department visits and hospitalizations measure different outcomes. Young children may account for a larger share of emergency visits, while adults 65 and older remain more likely to experience severe COVID-19 illness requiring hospitalization.

Q. Can national CDC data tell me which virus I have?

A. No. National surveillance shows population-level patterns and cannot diagnose an individual. Testing and a healthcare professional’s assessment may be needed, especially when treatment decisions depend on timing.

Q. Are the CDC findings applicable to Canada?

A. Not directly. The CDC data describe the United States. Canadian readers should use the Public Health Agency of Canada’s FluWatch+ surveillance report for Canadian activity, while recognizing that both countries can have different timing and regional patterns.